Cargando…
Safe and effective administration of T-VEC in a patient with heart transplantation and recurrent locally advanced melanoma
BACKGROUND: Immunotherapy plays a key role in the treatment of metastatic melanoma. Patients with autoimmune conditions and/or on immunosuppressive therapy due to orthotropic transplants, however, are systematically excluded from clinical trials. Talimogene laherparepvec (T-VEC) is the first oncolyt...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477138/ https://www.ncbi.nlm.nih.gov/pubmed/28642816 http://dx.doi.org/10.1186/s40425-017-0250-5 |